Welcome to our dedicated page for Tabula Rasa Heal news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa Heal stock.
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) provides investors and healthcare professionals with essential updates through this centralized news resource. As a leader in value-based care solutions, TRHC specializes in medication risk management and technology-driven healthcare optimization for at-risk populations.
This page aggregates official announcements including strategic partnerships, financial disclosures, and operational developments. Users will find updates on TRHC's pending merger with ExactCare Pharmacy under Nautic Partners, clinical program expansions, and innovations in personalized medication management systems.
Key content categories include earnings reports, merger/acquisition details, regulatory filings, and partnership announcements with PACE programs. All information is sourced directly from company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined access to TRHC's latest developments in healthcare technology and pharmacy services. For historical data and investor materials, visit the company's Investor Relations portal through their official website.
Tabula Rasa HealthCare (TRHC) has partnered with the American Society of Health-System Pharmacists (ASHP) to implement best practices for its MedWise™ software platform in health systems. The collaboration aims to enhance patient outcomes and pharmacy practices through technology-driven solutions. MedWise technology improves pharmacist workflows by identifying medication risk scores. ASHP, representing nearly 58,000 pharmacy professionals, will assist in evaluating MedWise's usage across various healthcare settings. This partnership aligns with the goal of optimizing medication use and reducing adverse drug events in patient care.
Tabula Rasa HealthCare (NASDAQ: TRHC) has expanded its partnership with MDVIP to integrate its MedWise™ Comprehensive Medication Management (CMM) Program into MDVIP Plus practices. This collaboration aims to enhance medication safety through the calculation of MedWise Risk Scores, addressing dangerous drug interactions that often lead to hospitalizations. Notably, a 2-point decrease in MRS corresponds to substantial cost savings. The integration includes a consumer-facing app, MedWise Mobile, to help patients track their medication management more effectively.
Micro Merchant Systems announced the integration of its PrimeRx™ pharmacy software with Tabula Rasa HealthCare's (TRHC) automated immunization reporting solution. This addition allows pharmacies to streamline the process of registering, recording, and reporting COVID-19 vaccinations. The latest version of PrimeRx™ includes features to manage necessary compliance data, enhancing pharmacies' operational efficiency during vaccination efforts. TRHC's solution connects with state immunization information systems, ensuring accurate reporting within regulatory timelines.
Tabula Rasa HealthCare (NASDAQ: TRHC) will announce its fourth quarter and full year 2020 financial results on February 23, 2021, after market close. A conference call to discuss these results is scheduled for February 24, 2021, at 8:30 a.m. EDT, led by CEO Calvin H. Knowlton, PhD, and other executives. TRHC specializes in patient-specific, data-driven technology that enhances medication management for healthcare organizations, improving patient outcomes and reducing costs.
Tabula Rasa HealthCare (TRHC) announces the integration of its MedWise Risk Score™ into the PrescribeWellness (PW) software, enhancing patient relationship management. This technology assesses medication risks, guiding pharmacists and prescribers in individualized medication decisions to reduce adverse drug events (ADEs) and improve patient care. The MedWise Risk Score incorporates pharmacogenomics and predicts ADEs based on a patient's complete medication list. This integration aims to lower healthcare costs and enhance patient safety through comprehensive medication safety reviews.
Tabula Rasa HealthCare (TRHC) has formed a partnership with RxResults, a pharmacy risk management firm, to develop a model aimed at identifying health plan savings and mitigating medication risks. This collaboration combines TRHC's MedWise™ medication decision support technology with RxResults' services to improve medication safety and efficacy. The partnership is expected to reduce healthcare costs by addressing drug toxicity issues and enhancing patient outcomes. Both companies aim to advocate for health plan sponsors and participants, creating financial savings and improved healthcare delivery.
Tabula Rasa HealthCare (TRHC) has partnered with the American Society of Health-System Pharmacists (ASHP) to offer the Bayesian dosing platform, DoseMeRx, to pharmacy professionals in small and rural hospitals. This partnership aims to help these hospitals efficiently comply with revised guidelines for vancomycin dosing in MRSA infections. The AUC-based monitoring method represents a significant shift from traditional trough-based dosing. The new offering includes the Pharmacy Competency Assessment Center (PCAC) to manage pharmacist competencies effectively.
Tabula Rasa HealthCare (TRHC) has partnered with Innovative Integrated Health Community Plans (IIHCP) to offer pharmacy benefit services aimed at enhancing Medicare Advantage (MA) programs in California's Fresno, Kern, and Tulare counties. This collaboration aims to assist IIHCP in achieving network adequacy as defined by CMS. Leveraging TRHC's expertise and nationwide pharmacy network, the partnership promises tailored solutions to improve patient care and optimize medication performance.
Tabula Rasa HealthCare (TRHC) announced participation in the 39th Annual J.P. Morgan Healthcare Conference, scheduled to be held virtually from January 11-14, 2021. CEO Calvin H. Knowlton and other executives will present on January 14, 2021, at 4:30 p.m. EST. An audio replay will be accessible on their investor relations website. TRHC specializes in patient medication safety solutions that enhance medication regimens and reduce risks related to adverse drug events, leveraging its MedWise™ technology to improve patient outcomes and lower healthcare costs.
Tabula Rasa HealthCare (TRHC) has partnered with Physiomics plc to enhance cancer treatment through personalized medicine. This collaboration aims to integrate Physiomics' docetaxel dosing model with TRHC's DoseMeRx platform, expected to improve drug dosing precision and patient outcomes. The initiative targets oncology, specifically the commonly used drug docetaxel. Both companies anticipate a revenue-generating contract following successful trial results. This partnership leverages TRHC's clinical decision support tools and Physiomics' expertise in oncology.
